These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25704758)

  • 1. Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes.
    Guest ST; Kratche ZR; Bollig-Fischer A; Haddad R; Ethier SP
    Exp Cell Res; 2015 Mar; 332(2):223-35. PubMed ID: 25704758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chaperonin-Containing TCP1 Complex (CCT) Promotes Breast Cancer Growth Through Correlations With Key Cell Cycle Regulators.
    Ghozlan H; Showalter A; Lee E; Zhu X; Khaled AR
    Front Oncol; 2021; 11():663877. PubMed ID: 33996588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells.
    Weng H; Feng X; Lan Y; Zheng Z
    J Ovarian Res; 2021 Jun; 14(1):82. PubMed ID: 34162426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and Clinical Characterization of CCT2 Expression and Prognosis
    Liu Q; Qi Y; Kong X; Wang X; Zhang W; Zhai J; Yang Y; Fang Y; Wang J
    Front Oncol; 2021; 11():614497. PubMed ID: 33869000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating Chaperonin-Containing TCP-1 subunit 2 as an essential component of the chaperonin complex for tumorigenesis.
    Showalter AE; Martini AC; Nierenberg D; Hosang K; Fahmi NA; Gopalan P; Khaled AS; Zhang W; Khaled AR
    Sci Rep; 2020 Jan; 10(1):798. PubMed ID: 31964905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chaperonin containing TCP1 as a marker for identification of circulating tumor cells in blood.
    Cox A; Martini A; Ghozlan H; Moroose R; Zhu X; Lee E; Khaled AS; Barr L; Alemany C; Fanaian N; Griffith E; Sause R; Litherland SA; Khaled AR
    PLoS One; 2022; 17(6):e0264651. PubMed ID: 35749519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Characterization of Expression Profiles and Prognostic Values of the Eight Subunits of the Chaperonin TRiC in Breast Cancer.
    Xu WX; Song W; Jiang MP; Yang SJ; Zhang J; Wang DD; Tang JH
    Front Genet; 2021; 12():637887. PubMed ID: 33815471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TCP1 ring complex is associated with malignancy and poor prognosis in hepatocellular carcinoma.
    Yao L; Zou X; Liu L
    Int J Clin Exp Pathol; 2019; 12(9):3329-3343. PubMed ID: 31934176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chaperonin containing TCP-1 (CCT/TRiC) is a novel therapeutic and diagnostic target for neuroblastoma.
    Cox A; Nierenberg D; Camargo O; Lee E; Khaled AS; Mazar J; Boohaker RJ; Westmoreland TJ; Khaled AR
    Front Oncol; 2022; 12():975088. PubMed ID: 36185250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer.
    Coghlin C; Carpenter B; Dundas SR; Lawrie LC; Telfer C; Murray GI
    J Pathol; 2006 Nov; 210(3):351-7. PubMed ID: 16981251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular chaperone TRiC/CCT binds to the Trp-Asp 40 (WD40) repeat protein WDR68 and promotes its folding, protein kinase DYRK1A binding, and nuclear accumulation.
    Miyata Y; Shibata T; Aoshima M; Tsubata T; Nishida E
    J Biol Chem; 2014 Nov; 289(48):33320-32. PubMed ID: 25342745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Expression and Prognostic Value of the TCP1 Ring Complex in Hepatocellular Carcinoma and Overexpressing Its Subunit 5 Promotes HCC Tumorigenesis.
    Liu J; Huang L; Zhu Y; He Y; Zhang W; Lei T; Xuan J; Xiao B; Li L; Zhou Q; Sun Z
    Front Oncol; 2021; 11():739660. PubMed ID: 34676169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.
    Shiang CY; Qi Y; Wang B; Lazar V; Wang J; Fraser Symmans W; Hortobagyi GN; Andre F; Pusztai L
    Breast Cancer Res Treat; 2010 Oct; 123(3):747-55. PubMed ID: 20024612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.
    Asanuma H; Torigoe T; Kamiguchi K; Hirohashi Y; Ohmura T; Hirata K; Sato M; Sato N
    Cancer Res; 2005 Dec; 65(23):11018-25. PubMed ID: 16322251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCT2, a newly identified aggrephagy receptor in mammals, specifically mediates the autophagic clearance of solid protein aggregates.
    Zhang Z; Klionsky DJ
    Autophagy; 2022 Jul; 18(7):1483-1485. PubMed ID: 35699934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of estrogen on global gene expression: identification of novel targets of estrogen action.
    Charpentier AH; Bednarek AK; Daniel RL; Hawkins KA; Laflin KJ; Gaddis S; MacLeod MC; Aldaz CM
    Cancer Res; 2000 Nov; 60(21):5977-83. PubMed ID: 11085516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth suppression of HER2-overexpressing breast cancer cells by berberine via modulation of the HER2/PI3K/Akt signaling pathway.
    Kuo HP; Chuang TC; Yeh MH; Hsu SC; Way TD; Chen PY; Wang SS; Chang YH; Kao MC; Liu JY
    J Agric Food Chem; 2011 Aug; 59(15):8216-24. PubMed ID: 21699261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification.
    Tanizaki J; Okamoto I; Fumita S; Okamoto W; Nishio K; Nakagawa K
    Oncogene; 2011 Sep; 30(39):4097-106. PubMed ID: 21499301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the AKT/mTOR and erbB pathways by gefitinib, perifosine and analogs of gonadotropin-releasing hormone I and II to overcome tamoxifen resistance in breast cancer cells.
    Block M; Gründker C; Fister S; Kubin J; Wilkens L; Mueller MD; Hemmerlein B; Emons G; Günthert AR
    Int J Oncol; 2012 Nov; 41(5):1845-54. PubMed ID: 22922893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chaperonin Containing TCP-1 Protein Level in Breast Cancer Cells Predicts Therapeutic Application of a Cytotoxic Peptide.
    Bassiouni R; Nemec KN; Iketani A; Flores O; Showalter A; Khaled AS; Vishnubhotla P; Sprung RW; Kaittanis C; Perez JM; Khaled AR
    Clin Cancer Res; 2016 Sep; 22(17):4366-79. PubMed ID: 27012814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.